Abstract |
Fibroblast growth factor 2 (FGF-2) and its main receptor FGFR1 have been shown to promote hepatic stellate cell (HSC) activation and proliferation. However, scant information is available on the anti-fibrogenic activity of FGFR1 inhibitors. The aim of this study was to assess the impact of a selective FGFR1 tyrosine kinase inhibitor NP603 on HSC proliferation and hepatic fibrosis. We demonstrated that rat primary HSCs secreted significant amounts of FGF-2, and its tyrosine phosphorylation of FGFR1 was attenuated by NP603. NP603 inhibited HSC activaton by measuring the expression of α-smooth muscle actin (α-SMA) and the production of type I collagen using ELISA. Furthermore, NP603 (25 μM) in vitro strongly suppressed HSC growth induced by FGF-2 (10 ng/ml) and FCS. This effect correlated with the suppression of extracellular-regulated kinase (ERK) activity and its downstream targets cyclin D1 and p21. In addition, PO NP603 (20 mg·kg(-1)·day(-1)) administration significantly decreased hepatic collagen deposition and α-SMA expression in CCl(4)-treated rats. Collectively, these studies suggest that selective blocking of the FGFR1-mediated pathway could be a promising therapeutic approach for the treatment of hepatic fibrosis.
|
Authors | Nan Lin, Si Chen, Weidong Pan, Linan Xu, Kunpeng Hu, Ruiyun Xu |
Journal | American journal of physiology. Cell physiology
(Am J Physiol Cell Physiol)
Vol. 301
Issue 2
Pg. C469-77
(Aug 2011)
ISSN: 1522-1563 [Electronic] United States |
PMID | 21543745
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Actins
- Ccnd1 protein, rat
- Cdkn1a protein, rat
- Collagen Type I
- Collagen Type I, alpha 1 Chain
- Cyclin-Dependent Kinase Inhibitor p21
- Indoles
- NP 603
- Propionates
- Protein Kinase Inhibitors
- smooth muscle actin, rat
- Fibroblast Growth Factor 2
- Cyclin D1
- Tyrosine
- Carbon Tetrachloride
- Fgfr1 protein, mouse
- Receptor, Fibroblast Growth Factor, Type 1
- Extracellular Signal-Regulated MAP Kinases
- MAP Kinase Kinase 1
|
Topics |
- Actins
(metabolism)
- Animals
- Carbon Tetrachloride
- Cell Proliferation
(drug effects)
- Cells, Cultured
- Collagen Type I
(metabolism)
- Collagen Type I, alpha 1 Chain
- Cyclin D1
(metabolism)
- Cyclin-Dependent Kinase Inhibitor p21
(metabolism)
- Dose-Response Relationship, Drug
- Enzyme-Linked Immunosorbent Assay
- Extracellular Signal-Regulated MAP Kinases
(metabolism)
- Fibroblast Growth Factor 2
(metabolism)
- Hepatic Stellate Cells
(drug effects, enzymology, pathology)
- Indoles
(pharmacology)
- Liver
(drug effects, enzymology, pathology)
- Liver Cirrhosis, Experimental
(chemically induced, enzymology, pathology, prevention & control)
- MAP Kinase Kinase 1
(genetics, metabolism)
- Male
- Phosphorylation
- Propionates
(pharmacology)
- Protein Kinase Inhibitors
(pharmacology)
- Rats
- Rats, Sprague-Dawley
- Receptor, Fibroblast Growth Factor, Type 1
(antagonists & inhibitors, metabolism)
- Signal Transduction
(drug effects)
- Time Factors
- Transfection
- Tyrosine
|